• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013-2017 年德国结核病例报告的完整性:一项清查研究的初步结果。

Completeness of tuberculosis case notifications in Germany in 2013-2017: first results of an inventory study.

机构信息

Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Robert Koch Institute, Centre for International Health Protection (ZIG), Berlin, Germany.

出版信息

BMC Infect Dis. 2020 Oct 17;20(1):766. doi: 10.1186/s12879-020-05467-9.

DOI:10.1186/s12879-020-05467-9
PMID:33069210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568379/
Abstract

BACKGROUND

Evaluating the completeness of tuberculosis (TB) notification data is important for monitoring of TB surveillance systems. We conducted an inventory study to calculate TB underreporting in Germany in 2013-2017.

METHODS

Acquisition of two pseudonymized case-based data sources (national TB notification data and antibiotic resistance surveillance data) was followed by two-source Capture-recapture (CRC) analysis, as case-based data from a third source was unavailable. Aggregated data on consumption of a key anti-TB drug (pyrazinamide [PZA]) was compared to an estimated need for PZA based on TB notification data to obtain an independent underreporting estimation. Additionally, notified TB incidence was compared to TB rate in an aggregated health insurance fund dataset.

RESULTS

CRC and PZA-based approaches indicated that between 93 and 97% (CRC) and between 91 and 95% (PZA) of estimated cases were captured in the national TB notification data in the years 2013-2017. Insurance fund dataset did not indicate TB underreporting on the national level in 2017.

CONCLUSIONS

Our results suggest that more than 90% of estimated TB cases are captured within the German TB surveillance system, and accordingly the TB notification rate is likely a good proxy of the diagnosed TB incidence rate. An increase in underreporting and discrepancies however should be further investigated.

摘要

背景

评估结核病(TB)报告数据的完整性对于监测结核病监测系统非常重要。我们进行了一项清查研究,以计算 2013-2017 年德国的结核病漏报率。

方法

获取两个化名的基于病例的数据源(国家结核病报告数据和抗生素耐药监测数据),然后进行两源捕获-再捕获(CRC)分析,因为第三个源的基于病例的数据不可用。将关键抗结核药物(吡嗪酰胺[PZA])的使用汇总数据与基于结核病报告数据估计的 PZA 需求进行比较,以获得独立的漏报估计。此外,将报告的结核病发病率与汇总的健康保险基金数据集的结核病率进行比较。

结果

CRC 和基于 PZA 的方法表明,2013-2017 年,国家结核病报告数据中分别有 93%至 97%(CRC)和 91%至 95%(PZA)的估计病例被捕获。保险基金数据集在 2017 年并未显示全国范围内的结核病漏报情况。

结论

我们的结果表明,德国结核病监测系统中捕获了超过 90%的估计结核病病例,因此结核病报告率很可能是诊断结核病发病率的良好替代指标。然而,漏报率的增加和差异应该进一步调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/55cb6db31e42/12879_2020_5467_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/a92759f592fb/12879_2020_5467_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/3ff88a5145cd/12879_2020_5467_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/6525f0a70e81/12879_2020_5467_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/183ce6b6e397/12879_2020_5467_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/55cb6db31e42/12879_2020_5467_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/a92759f592fb/12879_2020_5467_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/3ff88a5145cd/12879_2020_5467_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/6525f0a70e81/12879_2020_5467_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/183ce6b6e397/12879_2020_5467_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7096/7568379/55cb6db31e42/12879_2020_5467_Fig5_HTML.jpg

相似文献

1
Completeness of tuberculosis case notifications in Germany in 2013-2017: first results of an inventory study.2013-2017 年德国结核病例报告的完整性:一项清查研究的初步结果。
BMC Infect Dis. 2020 Oct 17;20(1):766. doi: 10.1186/s12879-020-05467-9.
2
Inventory study on completeness of tuberculosis case notifications in Poland in 2018.2018 年波兰结核病病例报告完整性的存量研究。
Euro Surveill. 2024 Jan;29(1). doi: 10.2807/1560-7917.ES.2024.29.1.2300081.
3
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.通过与抗结核药物消耗的比较评估希腊的结核病漏报情况。
PLoS One. 2012;7(11):e50033. doi: 10.1371/journal.pone.0050033. Epub 2012 Nov 21.
4
Capture-recapture to estimate completeness of tuberculosis surveillance in two communities in South Africa.捕获-再捕获法估计南非两个社区的结核病监测完整性。
Int J Tuberc Lung Dis. 2011 Aug;15(8):1038-43. doi: 10.5588/ijtld.10.0695.
5
Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016.结核病(TB)通报完整性:2014 年至 2016 年,六个欧盟国家的盘存研究和捕获-再捕获分析。
Euro Surveill. 2020 Mar;25(12). doi: 10.2807/1560-7917.ES.2020.25.12.1900568.
6
Overcoming the pitfalls of automatic interpretation of whole genome sequencing data by online tools for the prediction of pyrazinamide resistance in Mycobacterium tuberculosis.克服在线工具自动解释全基因组测序数据以预测结核分枝杆菌吡嗪酰胺耐药性的陷阱。
PLoS One. 2019 Feb 28;14(2):e0212798. doi: 10.1371/journal.pone.0212798. eCollection 2019.
7
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.中国南方耐多药结核分枝杆菌分离株中吡嗪酰胺耐药情况及分子特征分析
BMC Infect Dis. 2017 Nov 6;17(1):711. doi: 10.1186/s12879-017-2761-6.
8
Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.结核分枝杆菌对吡嗪酰胺药敏试验的熟练度:瑞典经验。
Int J Tuberc Lung Dis. 2013 Nov;17(11):1486-90. doi: 10.5588/ijtld.13.0195.
9
Completeness and timeliness of tuberculosis notification in Taiwan.台湾结核病通报的完整性和及时性。
BMC Public Health. 2011 Dec 12;11:915. doi: 10.1186/1471-2458-11-915.
10
Global status of phenotypic pyrazinamide resistance in clinical isolates: an updated systematic review and meta-analysis.全球临床分离株中表型吡嗪酰胺耐药性的现状:一项更新的系统评价和荟萃分析。
J Chemother. 2023 Nov;35(7):583-595. doi: 10.1080/1120009X.2023.2214473. Epub 2023 May 21.

引用本文的文献

1
On the estimation of population size-A comparison of capture-recapture and multiplier-benchmark methods.关于种群大小的估计——捕获-再捕获法与乘数-基准法的比较
Stat Methods Med Res. 2024 Oct;33(10):1818-1835. doi: 10.1177/09622802241275413. Epub 2024 Sep 30.
2
Incomplete tuberculosis reporting and registration to the surveillance system in southwestern China of Yunnan Province: an inventory survey.中国云南省西南部结核病报告和监测系统不完整:一项清查调查。
BMC Public Health. 2024 May 25;24(1):1397. doi: 10.1186/s12889-024-18794-2.
3
Inventory study on completeness of tuberculosis case notifications in Poland in 2018.

本文引用的文献

1
Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016.结核病(TB)通报完整性:2014 年至 2016 年,六个欧盟国家的盘存研究和捕获-再捕获分析。
Euro Surveill. 2020 Mar;25(12). doi: 10.2807/1560-7917.ES.2020.25.12.1900568.
2
Under-reporting of diagnosed tuberculosis to the national surveillance system in China: an inventory study in nine counties in 2015.中国国家监测系统中诊断结核病漏报情况:2015 年九个县的清查研究。
BMJ Open. 2019 Jan 28;9(1):e021529. doi: 10.1136/bmjopen-2018-021529.
3
Tuberculosis in Germany: a declining trend coming to an end?
2018 年波兰结核病病例报告完整性的存量研究。
Euro Surveill. 2024 Jan;29(1). doi: 10.2807/1560-7917.ES.2024.29.1.2300081.
4
Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.津巴布韦结核病队列分析:需要加强结核病护理级联中患者的随访。
PLoS One. 2023 Nov 8;18(11):e0293867. doi: 10.1371/journal.pone.0293867. eCollection 2023.
德国的结核病:下降趋势即将结束?
Eur Respir J. 2016 Feb;47(2):667-70. doi: 10.1183/13993003.01410-2015. Epub 2015 Oct 22.
4
[Current epidemiology of tuberculosis in Germany].[德国结核病的当前流行病学情况]
Pneumologie. 2015 May;69(5):263-70. doi: 10.1055/s-0034-1391922. Epub 2015 May 13.
5
From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.从药丸到患者:评估德国接受抗逆转录病毒治疗的艾滋病毒感染者人数的数据来源
BMC Public Health. 2015 Mar 17;15:252. doi: 10.1186/s12889-015-1598-4.
6
Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq.在资源有限的国家中估算结核病负担和报告:伊拉克的捕获-再捕获研究。
Int J Tuberc Lung Dis. 2013 Apr;17(4):462-7. doi: 10.5588/ijtld.12.0209.
7
Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen.在资源有限的国家估算结核病负担:也门的捕获-再捕获研究。
Int J Tuberc Lung Dis. 2013 Apr;17(4):456-61. doi: 10.5588/ijtld.11.0483.
8
Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption.通过与抗结核药物消耗的比较评估希腊的结核病漏报情况。
PLoS One. 2012;7(11):e50033. doi: 10.1371/journal.pone.0050033. Epub 2012 Nov 21.
9
[Antimicrobial resistance in Germany. Four years of antimicrobial resistance surveillance (ARS)].[德国的抗菌药物耐药性。四年抗菌药物耐药性监测(ARS)]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Nov;55(11-12):1370-6. doi: 10.1007/s00103-012-1559-3.
10
Evaluation of underreporting tuberculosis in Central Italy by means of record linkage.利用记录链接评估意大利中部的结核病漏报情况。
BMC Public Health. 2012 Jun 21;12:472. doi: 10.1186/1471-2458-12-472.